Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biol Proced Online
2008 Jan 17;10:1-8. doi: 10.1251/bpo137.
Show Gene links
Show Anatomy links
In vivo and in vitro techniques for comparative study of antiviral T-cell responses in the amphibian Xenopus.
Morales H
,
Robert J
.
???displayArticle.abstract???
Activation of lymphocytes in mammals is often quantified by measuring the amount of proliferation during the expansion phase of an immune response. Bromodeoxyuridine (BrdU) incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution assays are some of the techniques widely used in mammalian studies of pathogen-induced proliferation and provide a convenient way of quantifying the cellular response. We have extended the use of these proliferation assays to the amphibian Xenopus laevis. We have developed this species as a valuable comparative model to study immunity against a well-known amphibian pathogen, Frog Virus 3 (FV3). Fluorescence activated cell sorting was used to assess the level of BrdU incorporation of lymphocytes in vivo and CFSE dilution in an in vitro activation assay. Both techniques have shown that splenic lymphocytes proliferate specifically upon FV3 challenge. This indicates that common methods for detection of proliferation upon immunologic challenge are easily applied to other vertebrate species, as it highlights the evolutionary conservation of the proliferative nature of immune responses throughout vertebrate phyla.
Fig. 1
Detection of Xenopus splenocyte proliferation 6 days post-FV3 infection by BrdU assay. Uninfected control frogs and frogs infected for 6 days with FV3 were treated with BrdU 48 hrs before the assay. Cells were then permeabilized, treated with DNase, stained with FITC-conjugated anti-BrdU mAb, and analyzed by FACS (Representative of six different experiments). Ten thousand total events were gated based on side and forward scatter profiles (A, C). The arrows depict cells with higher forward scatter that increase in number in the infected sample. The percent of gated BrdU positive cells is shown in the histograms (B, D).
Fig. 2
Proliferation of CD8+ T and IgM+ B cells 6 days post-FV3 infection detected by BrdU assay. Representative two-color flow cytometry analysis of splenocytes from uninfected control frogs (A), and frogs infected for 6 days (B). Splenocytes were surface stained for Xenopus MHC Class II (AM20), CD8 (AM22) or IgM (10A9) followed by APC-conjugated goat anti-mouse secondary antibody. Cells were then permeabilized, treated with DNase and stained with FITC-conjugated anti-BrdU mAb and analyzed by FACS. Twenty thousand total events were gated based on side and forward scatter profiles as in Fig. 1. The number in the upper right quadrant indicates the percent of double positive cells.
Fig. 3
Detection of Xenopus primed splenocyte proliferation induced in vitro by FV3 infected FV3 peritoneal leukocytes using the CFSE assay. Splenocytes from an uninfected control frog or a frog primed 3 weeks before the assay by infection with FV3 were CFSE stained and co-cultured for 72 hours with FV3 infected peritoneal leukocytes obtained from the same frogs 3 days before the assay. Total culture was surface stained for MHC class II (AM20) or CD8 (AM22) and analyzed by FACS. A time zero analysis shows initial CFSE staining of splenocytes prior to co-culture. Analysis at 72 hrs (B) was done on gated population in the side scatter dot plot (A). Numbers in upper left quadrant indicates the percent of CD8 or Class II positive cells with diluted CFSE.
Carayon,
Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA.
1992, Pubmed
Carayon,
Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA.
1992,
Pubmed
Doherty,
Roles of alpha beta and gamma delta T cell subsets in viral immunity.
1992,
Pubmed
Estepa,
Viral-antigen dependence and T-cell receptor expression in leucocytes from rhabdovirus immunized trout.
1999,
Pubmed
Gantress,
Development and characterization of a model system to study amphibian immune responses to iridoviruses.
2003,
Pubmed
,
Xenbase
Gonchoroff,
S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment.
1986,
Pubmed
Hasbold,
Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester.
1999,
Pubmed
Hsu,
Studies on Xenopus immunoglobulins using monoclonal antibodies.
1984,
Pubmed
,
Xenbase
Klenerman,
T cells and viral persistence: lessons from diverse infections.
2005,
Pubmed
Lyons,
Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.
2000,
Pubmed
Lyons,
Determination of lymphocyte division by flow cytometry.
1994,
Pubmed
Maniero,
Generation of a long-lasting, protective, and neutralizing antibody response to the ranavirus FV3 by the frog Xenopus.
2006,
Pubmed
,
Xenbase
Migueles,
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
2002,
Pubmed
Morales,
Characterization of primary and memory CD8 T-cell responses against ranavirus (FV3) in Xenopus laevis.
2007,
Pubmed
,
Xenbase
Pantaleo,
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.
2006,
Pubmed
Reimann,
Introduction of a selectable gene into murine T-lymphoblasts by a retroviral vector.
1986,
Pubmed
Robert,
Adaptive immunity and histopathology in frog virus 3-infected Xenopus.
2005,
Pubmed
,
Xenbase
Robert,
Xenopus as an experimental model for studying evolution of hsp--immune system interactions.
2004,
Pubmed
,
Xenbase
Tough,
Turnover of naive- and memory-phenotype T cells.
1994,
Pubmed
Vanderlaan,
Characterization of monoclonal antibodies to bromodeoxyuridine.
1985,
Pubmed
Weekes,
Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population.
1999,
Pubmed